Latest News about KRTX
Recent news which mentions KRTX
From Benzinga
Mental Health Mavericks: 3 Stocks Changing the Game
February 21, 2024
From InvestorPlace
This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space
February 16, 2024
From Benzinga
UBS Bullish On This Depression Drug Maker, Says Alzheimer's Agitation Data Is Attractive Catalyst
February 06, 2024
From Benzinga
Mizuho Downgrades Karuna Therapeutics: Here's What You Need To Know
January 26, 2024
Tickers
KRTX
From Benzinga
5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday
January 08, 2024
From Benzinga
From Benzinga
Bristol-Myers' Acquisition Of Karuna Therapeutics Paves Way For Aggressive Global Marketing Of KarXT: Analyst
December 26, 2023
From Benzinga
Why Is RayzeBio (RYZB) Stock Up 100% Today?
December 26, 2023
From InvestorPlace
Cognizant Technology Solutions To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Tuesday
December 26, 2023
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 25, 2023
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 25, 2023
From Benzinga
Dow Edges Lower; Nike Sales Miss Estimates
December 22, 2023
From Benzinga
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 22, 2023
From Benzinga
S&P 500, Nasdaq 100 Aim For 8th Week Of Gains As Fed's Inflation Gauge Cools: What's Driving Markets Friday?
December 22, 2023
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 22, 2023
From Benzinga
Gold Moves Higher; US Consumer Sentiment Improves In December
December 22, 2023
From Benzinga
With Karuna Therapeutics $14B Deal, Bristol Myers Is Serious For Re-Establishing Its Neurology Portfolio: Analyst
December 22, 2023
From Benzinga
Karuna Therapeutics Jumps Following Takeover By Bristol Myers, Joins Rocket Lab USA, Altair Engineering And Other Big Stocks Moving Higher On Friday
December 22, 2023
From Benzinga
Health Care Company Bristol-Myers Squibb Announces Merger With Karuna Therapeutics
December 22, 2023
From Benzinga
Dow Rises 50 Points; Fed's Preferred Inflation Gauge Cools In November
December 22, 2023
From Benzinga
Bristol Myers Squibb Scoops Up Schizophrenia Player Karuna Therapeutics In Massive $14B Deal
December 22, 2023
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 22, 2023
From Benzinga
Karuna Therapeutics Says Its Antipsychotic Candidate Shows Favorable Cardiovascular Safety Profile In Schizophrenia Patients
November 17, 2023
Tickers
KRTX
From Benzinga
What 9 Analyst Ratings Have To Say About Karuna Therapeutics
September 28, 2023
Tickers
KRTX
From Benzinga